Elevated serum CA-125 levels have been associated with various gynecological malignancies (fallopian tube cancer and endometrial cancer), particularly ovarian cancer, making it a clinically relevant biomarker for this disease [7]. The gene discussed is MUC16; the disease is fallopian tube cancer.